Analysis of risk factors of type a aortic dissection (TAAD) operation of frozen elephant trunk and total arch replacement.

Wei Shang; Meletios A Dimopoulos; Ge Yp; Nan Liu; Zhu Jm; Sun Lz

Abstract

1 min read

The incidence of ARF after the operation was 9.7%. Preoperative serum creatinine ≥200 µmol/L, hypertension history and extracorporeal circulation duration ≥260 min were independent risk factors of ARF after the operation. The five-year survival rate of ARF after the operation was 56%. The preoperative serum creatinine level had no influence on the postoperative long-term survival.

Related publications

Article2000

Decreased Protein C, Protein S and Antithrombin III Levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei

SP LaRosa, S M Opal, B G Utterback, Bo‐Shiun Yan, Jeffrey D. Helterbrand, A. John Simpson, Sir Nicholas White, CJ Fisher

Critical Care

Article2000

The ex vivo production of tumor necrosis factor-α (TNF-α) in men: relationship to cytokine balance during cardiopulmonary bypass

Y Tabardel, Laure Dumont, Denis Schmartz, Jean Louis Vincent, Jean Duchateau

Article2021

Integrative Analysis of Metabolomics and Transcriptomics Data Identifies Prognostic Biomarkers Associated With Oral Squamous Cell Carcinoma

Lihua Zuo, Zhuo Chen, Lihuang Chen, Jian Jian Kang, Yingying Shi, Liwei Liu, Shu‐Hua Zhang, Qingquan Jia, Yi Huang, Zhi Sun

Article2021

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism

Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S. Wells, Clive Kearon, Jeffrey I. Weitz, Harry R. Büller, Gary E. Raskob, Walter Ageno, Françis Couturaud, Paolo Prandoni, Gualtiero Palareti, Cristina Legnani, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Geert‐Jan Geersing, Toshihiko Takada, Benilde Cosmi, ,

Article2016

Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma

K. Weisel, Meletios A Dimopoulos, Philippe Moreau, Martha Q. Lacy, Kevin Song, M. Delforge, Lionel Karlin, Hartmut Goldschmidt, A. Baños, Albert Oriol, Adrían Alegre, C. Chen, Michèle Cavo, Laurent Garderet, V. L. Ivanova, Joaquín Martínez‐López, Stefan Knop, Xiaoyan Yu, Kevin Hong, Lars Sternås, Christian Jacques,